Edgar Jannotta, a former GTCR managing principal, is one of the investors in the orthopedic device company.
All parties are looking to ArthroCAD to develop safer, more accurate implants for THA.
More Articles on Devices:
Zimmer to Close Austin Device Plant in July
MAKO Surgical Gives $265k Research Grant to Rebound Orthopedics & Neurosurgery
AxioMed Spine Collects $3.6M in Device Development Funding
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
